Radiation following chemotherapy for mediastinal Hodgkin's disease: the outcome of various doses for bulky tumors

被引：3
作者：
Eisbruch, A
Kazerooni, EA
Sahijdak, WM
Francis, IR
Lichter, AS
机构：
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA
来源：
RADIOTHERAPY AND ONCOLOGY | 1998年 / 46卷 / 01期
关键词：
radiation; chemotherapy; Hodgkin's disease; bulky tumors;
D O I：
10.1016/S0167-8140(97)00161-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Twenty-one patients with bulky mediastinal disease responding to chemotherapy received consolidation with low-dose mediastinal radiation (19.8-25.2 Gy). Their 5-year mediastinal failure rate (10%) was equivalent to that of 10 similar patients who received higher doses of 30-44 Gy (20%). Low-dose radiation may be appropriate for these patients. Prospective studies are required to verify these findings. (C) 1998 Elsevier Science Ireland Ltd.
引用
收藏
页码：47 / 49
页数：3
相关论文
共 50 条
[21]   Mediastinal bulky tumour in Hodgkin's disease and prognostic value of positron emission tomography in the evaluation of post-treatment residual masses [J].
Keresztes, K ;
Lengyel, Z ;
Devenyi, K ;
Vadasz, G ;
Miltenyi, Z ;
Illes, A .
ACTA HAEMATOLOGICA, 2004, 112 (04) :194-199
[22]   BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease [J].
Diehl, V ;
Sieber, M ;
Ruffer, U ;
Lathan, B ;
Hasenclever, D ;
Pfreundschuh, M ;
Loeffler, M ;
Lieberz, D ;
Koch, P ;
Adler, M ;
Tesch, H .
ANNALS OF ONCOLOGY, 1997, 8 (02) :143-148
[23]   Intensified ABVP chemotherapy for the primary treatment of Hodgkin's disease [J].
Spector, N ;
Costa, MA ;
Morais, JC ;
Biasoli, I ;
Solza, C ;
Gaui, MD ;
Ferreira, CG ;
Portugal, RD ;
Loureiro, M ;
Nucci, M ;
Pulcheri, W .
ONCOLOGY REPORTS, 2002, 9 (02) :439-442
[24]   Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy [J].
Reddy, AT ;
Janss, AJ ;
Phillips, PC ;
Weiss, HL ;
Packer, RJ .
CANCER, 2000, 88 (09) :2189-2193
[25]   Cardiac risk after mediastinal irradiation for Hodgkin's disease [J].
Glanzmann, C ;
Kaufmann, P ;
Jenni, R ;
Hess, OM ;
Huguenin, P .
RADIOTHERAPY AND ONCOLOGY, 1998, 46 (01) :51-62
[26]   Bronchial erosion of mediastinal lymphadenopathy associated with Hodgkin's disease [J].
Brinchault, G ;
Rochefort-Morel, C ;
Morel, V ;
Edan, C ;
Caulet-Maugendre, S ;
Lena, H ;
Delaval, P .
REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (01) :137-140
[27]   Augmented therapy of extensive Hodgkin's disease: Radiation to known disease or prolongation of induction chemotherapy did not improve survival - Results of a cancer and leukemia group B study [J].
Coleman, M ;
Rafla, S ;
Propert, KJ ;
Glicksman, A ;
Peterson, B ;
Nissen, N ;
Brunner, K ;
Holland, JF ;
Anderson, JR ;
Gottlieb, A ;
Kaufman, T .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (03) :639-645
[28]   BULKY MEDIASTINAL HODGKINS-DISEASE - RESULTS OF A COMBINED-MODALITY APPROACH (ABVD MOPP ALTERNATING CHEMOTHERAPY PLUS RADIATION-THERAPY) [J].
DELENA, M ;
DITONNO, P ;
LORUSSO, V ;
TIMURIAN, A ;
PELLECCHIA, A ;
BRANDI, M ;
BERARDI, F ;
MARZULLO, F .
HAEMATOLOGICA, 1993, 78 (04) :230-235
[29]   Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy [J].
Elconin, JH ;
Roberts, KB ;
Rizzieri, DA ;
Vermont, C ;
Clough, RW ;
Kim, C ;
Dodge, RK ;
Prosnitz, LR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (04) :1097-1105
[30]   The evolving role of radiation therapy in pediatric Hodgkin's disease [J].
Fredman, Elisha ;
Mansur, David B. ;
Russo, Suzanne .
EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (06) :605-613
12345